Evidence map›Paper›PMID 37960842›Full record

ArticleTechnology in cancer research & treatment

Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.

Maiko Machida, Mayuko Ambo, Runa Mishina, Nanaka Hada, Fuhito Tachibana, Miki Yamashita, Ainari Konda, Kunihiko Tsuji

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Predicting response to patients with gastric cancer via a dynamic-aware model with longitudinal liquid biopsy data.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maiko MachidaDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.ORCID 0000-0002-3610-8916
Mayuko AmboDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Runa MishinaDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Nanaka HadaDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Fuhito TachibanaDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Miki YamashitaDepartment of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Ainari KondaDepartment of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Hokkaido, Japan.
Kunihiko TsujiTeine Keijinkai Hospital, Center of Gastroenterology, Sapporo Hokkaido, Japan.
Hokkaido University of Science · JPTeine Keijinkai Hospital · JP

Funding

Japan Society for the Promotion of Science Grants-Aid for Scientific Research 21K06648
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsalpha-FetoproteinsBiomarkersBiomarkers, TumorHumansInterleukin-10Interleukin-17Liver CirrhosisPilot ProjectsProspective StudiesProtein PrecursorsProthrombinROC Curvealpha-FetoproteinsBiomarkersBiomarkers, TumorIL10 protein, humanIL17A protein, humanInterleukin-10Interleukin-17MicroRNAsMIRN21 microRNA, humanProtein PrecursorsProthrombinbiomarkerhepatocellular carcinomaliquid biopsymiR-21-5ppropensity score

Identifiers

PMID37960842
PMCPMC10647953
OpenAlexW4388669103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.